share_log

藥明康德：截至二零二四年三月三十一日止月份之股份發行人的證券變動月報表

WUXI APPTEC: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024

香港交易所 ·  Apr 2 04:52
Summary by Moomoo AI
無錫藥明康德於2024年3月份的股份變動月報表顯示，公司H股股份數量維持不變，而A股股份經歷了減少。根據報表，A股股份在3月份減少了20,151,949股，結存為2,546,251,740股。此外，公司於3月份行使了2019年A股激勵計劃下的股票期權，新增了123,458股A股。同時，公司在3月11日至29日間回購了6,519,226股H股，但這些股份尚未註銷。報表亦提及，公司已完成對於2024年2月5日回購的20,275,407股A股的註銷。這些變動均已獲得董事會的正式授權批准。
無錫藥明康德於2024年3月份的股份變動月報表顯示，公司H股股份數量維持不變，而A股股份經歷了減少。根據報表，A股股份在3月份減少了20,151,949股，結存為2,546,251,740股。此外，公司於3月份行使了2019年A股激勵計劃下的股票期權，新增了123,458股A股。同時，公司在3月11日至29日間回購了6,519,226股H股，但這些股份尚未註銷。報表亦提及，公司已完成對於2024年2月5日回購的20,275,407股A股的註銷。這些變動均已獲得董事會的正式授權批准。
Wuxi Pharmaceutical Ming Kand's Stock Change Month Report for March 2024 showed that the number of shares of the company H shares remained unchanged, while the A shares experienced a decrease. According to the report, A shares decreased by 20,151,949 shares in March to 2,546,251,740 shares. In addition, the Company exercised stock options under the A-share incentive program in March 2019, adding 123,458 shares of A-shares. At the same time, the company repurchased 6,519,226 shares of H shares between March 11 and 29, but these shares have not been withdrawn. The report also mentions that the Company has completed write-offs of 20,275,407 shares of Class A shares repurchased on February 5, 2024. These changes have been formally authorized by the Board of Directors.
Wuxi Pharmaceutical Ming Kand's Stock Change Month Report for March 2024 showed that the number of shares of the company H shares remained unchanged, while the A shares experienced a decrease. According to the report, A shares decreased by 20,151,949 shares in March to 2,546,251,740 shares. In addition, the Company exercised stock options under the A-share incentive program in March 2019, adding 123,458 shares of A-shares. At the same time, the company repurchased 6,519,226 shares of H shares between March 11 and 29, but these shares have not been withdrawn. The report also mentions that the Company has completed write-offs of 20,275,407 shares of Class A shares repurchased on February 5, 2024. These changes have been formally authorized by the Board of Directors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more